Bostom Andrew G, Kronenberg Florian, Ritz Eberhard
Division of Renal Diseases, Rhode Island Hospital, Providence, Rhode Island 02903, USA.
J Am Soc Nephrol. 2002 Aug;13(8):2140-4. doi: 10.1097/01.asn.0000022011.35035.f3.
Accurate renal function measurements are important for the diagnosis and treatment of kidney disease, proper medication dosing, interpretation of possible uremic symptoms, and decision-making regarding when to initiate renal replacement therapy. Because the use of highly accurate filtration markers to measure renal function has traditionally been limited by cumbersome and costly techniques and the involvement of radioactivity (among other factors), renal function is typically estimated by using specially derived prediction equations. These formulae usually use serum creatinine levels, i.e., a marker of filtration that is insensitive to mild/moderate decreases in GFR. Although attempts have been made to validate certain renal function prediction equations among patients with chronic kidney disease (CKD) with abnormal serum creatinine levels, this is the first study to specifically evaluate the predictive performance of these equations for patients with CKD and serum creatinine levels in the normal range. The results of eight prediction equations for 109 patients with CKD and serum creatinine levels of < or =1.5 mg/dl were compared with standard iohexol GFR values. The most accurate results were obtained with the Cockroft-Gault and Bjornsson equations. The most precise formulae were the Modification of Diet in Renal Disease Study equations, although they were highly biased. Even the most accurate results exhibited levels of error that made them suboptimal for clinical treatment of these patients. These results suggest that measurement of GFR with endogenous or exogenous filtration markers might be the most prudent strategy for the assessment of renal function in the CKD population with normal serum creatinine levels. Further studies are needed to confirm the generalizability of these findings for this patient subgroup.
准确测量肾功能对于肾脏疾病的诊断和治疗、合理用药剂量、解读可能的尿毒症症状以及决定何时开始肾脏替代治疗都很重要。由于传统上使用高度准确的滤过标志物来测量肾功能受到技术繁琐、成本高昂以及放射性因素(以及其他因素)的限制,肾功能通常通过使用专门推导的预测方程来估算。这些公式通常使用血清肌酐水平,即一种对肾小球滤过率(GFR)轻度/中度下降不敏感的滤过标志物。尽管已经尝试在血清肌酐水平异常的慢性肾脏病(CKD)患者中验证某些肾功能预测方程,但这是第一项专门评估这些方程对血清肌酐水平在正常范围内的CKD患者预测性能的研究。将109例血清肌酐水平≤1.5mg/dl的CKD患者的八个预测方程的结果与标准碘海醇GFR值进行了比较。Cockroft-Gault方程和Bjornsson方程得出的结果最准确。最精确的公式是肾脏疾病饮食改良研究方程,尽管它们存在高度偏差。即使是最准确的结果也显示出误差水平,使其在这些患者的临床治疗中并非最佳选择。这些结果表明,使用内源性或外源性滤过标志物测量GFR可能是评估血清肌酐水平正常的CKD人群肾功能的最谨慎策略。需要进一步研究以证实这些发现对该患者亚组的普遍性。